Open Heart

FEBRUARY 17, 2025

Background Despite limited beneficial evidence, mechanical circulatory support (MCS) is commonly used in patients with acute myocardial infarction-related cardiogenic shock (AMI-CS). In this Dutch registry, we investigated MCS usage, associated patient characteristics and clinical outcomes.

Cardiogenic Shock 52

Cardiogenic Shock Myocardial Infarction Aortic Outcomes 52

Med Page Today

JUNE 26, 2024

(MedPage Today) -- Influenza infection was associated with an increased risk of acute myocardial infarction (MI), especially for those without a prior hospitalization for coronary artery disease (CAD), according to a Dutch observational case series.

Heart Attack 143

Heart Attack Heart attacks Coronary Artery Disease Myocardial Infarction 143

HCPLive

FEBRUARY 10, 2025

Cardiovascular hospitalization rates were higher in the US than in Denmark, driven by a significant increase in heart failure and myocardial infarction hospitalizations.

Hospital 78

Hospital Myocardial Infarction Heart Failure 78

American College of Cardiology

APRIL 6, 2024

The goal of the EMPACT-MI trial was to determine whether adding the sodium-glucose cotransporter-2 (SGLT2) inhibitor empagliflozin to the treatment of acute myocardial infarction (AMI) affects future mortality or heart failure (HF) in at-risk patients.

Myocardial Infarction 66

Myocardial Infarction Heart Failure Hospital Article 66

Frontiers in Cardiovascular Medicine

JANUARY 15, 2024

Background The diagnosis of a left ventricular (LV) thrombus in patients with ST-segment elevation myocardial infarction (STEMI) remains challenging. All patients underwent transthoracic echocardiography (TTE) and CMRI during their index hospitalization. Methods We retrospectively evaluated 337 consecutive STEMI patients.

Myocardial Infarction 80

Myocardial Infarction STEMI Hospital 80

Frontiers in Cardiovascular Medicine

OCTOBER 7, 2024

BackgroundCardiac rupture (CR) after acute myocardial infarction (AMI) is a fatal mechanical complication. The purpose of our study was to discover relevant risk factors for CR after AMI and in-hospital mortality from CR.MethodsIn this study, we enrolled 1,699 AMI cases from October 2013 to May 2020.

Myocardial Infarction 59

Myocardial Infarction Risk Factors Hospital 59

European Journal of Heart Failure

DECEMBER 26, 2024

HF, heart failure; LVEF, left ventricular ejection fraction; MI, myocardial infarction. Abstract Aims In the EMPACT-MI trial, empagliflozin reduced heart failure (HF) hospitalizations but not mortality in acute myocardial infarction (MI). The primary endpoint was time to first HF hospitalization or all-cause death.

Myocardial Infarction 69

Myocardial Infarction Diabetes Heart Failure Hospital 69

Journal of the American Heart Association

MARCH 7, 2025

The primary outcome was device success and allcause death, while secondary outcomes included myocardial infarction, stroke, and heart failure hospitalization rates at 30day and intermediateterm followup. Studies with <5 patients were excluded. A fixedeffects metaanalysis was used to estimate pooled rates.

Cardiogenic Shock 45

Cardiogenic Shock Bicuspid/Mitral Myocardial Infarction Heart Failure 45

Coronary Artery Disease Journal

OCTOBER 23, 2023

Background Acute myocardial infarction (AMI) is one of the most lethal complications of COVID-19 hospitalization. In this study, we looked for the occurrence of AMI and its effects on hospital outcomes among COVID-19 patients. All COVID-19 hospitalizations with age ≥ 18 years were included in the analyses.

COVID-19 52

COVID-19 Myocardial Infarction Hospital ICU 52

American College of Cardiology

AUGUST 30, 2024

The goal of the ABYSS trial was to evaluate beta-blocker interruption compared with beta-blocker continuation after an uncomplicated myocardial infarction (MI).

Myocardial Infarction 56

Myocardial Infarction Hospital Article 56

American College of Cardiology

APRIL 6, 2024

The SGLT2 inhibitor empagliflozin did not lower the risk of a first hospitalization for heart failure (HF) or death from any cause among patients with an increased risk for HF following acute myocardial infarction (MI), according to the results of the EMPACT-MI study, presented during a Late-Breaking Clinical Trial session at ACC.24

Hospital 74

Hospital Myocardial Infarction Heart Failure Article 74

Journal of the American Heart Association

DECEMBER 20, 2024

BackgroundPreclinical studies demonstrate a cardioprotective role of eosinophils in acute myocardial infarction. Yet clinical studies show conflicting correlations between blood eosinophil counts and acute myocardial infarction risk and mortality.

Myocardial Infarction 45

Myocardial Infarction Hospital 45

Cardiovascular Diabetology

JANUARY 8, 2024

Myocardial infarction (MI), stroke, peripheral arterial disease (PAD), heart failure (HF) and chronic kidney disease (CKD) are common cardiovascular renal diseases (CVRD) manifestations for type 2 diabetes.

Peripheral Arterial Disease 105

Peripheral Arterial Disease Myocardial Infarction Kidney Disease Diabetes 105

Open Heart

JANUARY 19, 2025

Secondary endpoints were in-hospital mortality, 1-year mortality, bleeding, major vascular complications, myocardial infarction, stroke, incidence of pacemaker implantation, acute kidney injury and aortic regurgitation. Methods A systematic literature review and meta-analysis was performed.

Cardiogenic Shock 52

Cardiogenic Shock Aortic Stenosis Aortic valve 52

Journal of Cardiothoracic Surgery

JUNE 25, 2024

Following an acute myocardial infarction (AMI), surgery for left ventricular free wall rupture (LVFWR) and ventricular septal rupture (VSR) has a high in-hospital mortality rate, which has not improved signifi.

Myocardial Infarction 52

Myocardial Infarction Hospital 52

European Journal of Heart Failure

FEBRUARY 16, 2025

ADHF-CS, acutely decompensated heart failure-related cardiogenic shock; AMI-CS, acute myocardial infarction-related cardiogenic shock; CI, confidence interval; HR, hazard ratio; MAP, mean arterial pressure; OPP, organ perfusion pressure; SOFA, Sequential Organ Failure Assessment. The primary outcome was in-hospital all-cause mortality.

Cardiogenic Shock 40

Cardiogenic Shock Outcomes Myocardial Infarction Heart Failure 40

Frontiers in Cardiovascular Medicine

JULY 22, 2024

IntroductionIn developing countries, there is a notable scarcity of real-world data on adherence to optimal medical therapy (OMT) and its correlation with major cardiovascular adverse events (MACEs) after ST-elevation myocardial infarction (STEMI). Patients were followed up for 4.5 ResultsWe included 349 patients with a mean age of 58.08

Myocardial Infarction 59

Myocardial Infarction Risk Factors Cardiogenic Shock STEMI 59

Frontiers in Cardiovascular Medicine

FEBRUARY 24, 2025

This case report describes a unique instance of a patient developing AEF following AF ablation, accompanied by ischemic stroke and myocardial infarction. Upon admission, physical examination and laboratory tests revealed vital signs within abnormal ranges and indicators suggesting inflammation and potential myocardial injury.

Atrial Fibrillation 52

Atrial Fibrillation Ablation Cardiogenic Shock Myocardial Infarction 52

Journal of the American Heart Association

MARCH 27, 2025

BackgroundRecent evidence highlights an increasing incidence of myocardial infarction in young women. years]) admitted to the China Chest Pain Center Database between 2016 and 2021.

Myocardial Infarction 40

Myocardial Infarction Peripheral Arterial Disease Outcomes Chest Pain 40

Frontiers in Cardiovascular Medicine

MARCH 19, 2024

Therefore, this paper proposes a novel cost-sensitive deep neural network (CSDNN)-based mortality prediction model for out-of-hospital acute myocardial infarction (AMI) patients with hypertension on imbalanced data. Methods The synopsis of our research is as follows.

Myocardial Infarction 64

Myocardial Infarction Hypertension Risk Factors Cardiovascular Disease 64

Frontiers in Cardiovascular Medicine

APRIL 2, 2025

IntroductionA rapid resting heart rate following acute myocardial infarction (AMI) predicts poor prognosis, making heart rate control crucial in treatment. However, it had no effect on the 12-month incidence of hospitalization for heart failure and cardiovascular death after discharge.

Myocardial Infarction 52

Myocardial Infarction Heart Failure Hospital Cardiac Function 52

Frontiers in Cardiovascular Medicine

FEBRUARY 11, 2025

BackgroundThe acute myocardial infarction (AMI) is a prevalent and severe cardiovascular disease, characterized by its sudden onset, high mortality rate, and unfavorable prognosis. The patients were divided into dapagliflozin group and control group according to whether they took dapagliflozin during hospitalization.

Myocardial Infarction 52

Myocardial Infarction Diabetes Heart Failure Laboratory 52

Frontiers in Cardiovascular Medicine

DECEMBER 20, 2023

Background As a sensitive diagnostic marker for myocardial infarction (MI) in people with normal renal function, elevated high sensitivity cardiac troponin T (hs-cTnT) was often found in chronic kidney disease (CKD) patients requiring dialysis.

Myocardial Infarction 64

Myocardial Infarction Kidney Disease Hospital 64

JAMA Cardiology

APRIL 6, 2024

This secondary analysis of a randomized clinical trial examines the antibody response to high-dose trivalent compared with standard-dose quadrivalent inactivated influenza vaccine in patients with a recent acute myocardial infarction or heart failure hospitalization.

Cardiovascular Disease 85

Cardiovascular Disease Myocardial Infarction Heart Failure Hospital 85

Frontiers in Cardiovascular Medicine

JANUARY 19, 2025

IntroductionHypoxic liver injury (HLI) and Killip classification are poor prognostic factors in patients with ST-segment elevation myocardial infarction (STEMI). In-hospital mortality was directly related to Killip classification (2.3%, 7.3%, 16.3%, 29.2%) with statistical significance.

Myocardial Infarction 52

Myocardial Infarction STEMI Biomarkers Hospital 52

Frontiers in Cardiovascular Medicine

JANUARY 9, 2024

Background Left ventricular free-wall rupture (LVFWR) is a catastrophic complication of acute myocardial infarction (AMI). However, because of the rarity of this entity, little is known regarding the efficacy and safety of surgical treatment for post-infarction LVFWR. The in-hospital mortality rate was 28.6%.

Myocardial Infarction 59

Myocardial Infarction Cardiac Arrest Risk Factors Hospital 59

Circulation

NOVEMBER 11, 2024

We compared in-hospital outcomes based on the presence versus absence of Group 2 PH. Multivariable regression models were used to adjust for confounders.Results:Among 182,308 AMI hospitalizations, 364 (0.2%) had a secondary diagnosis of Group 2 PH. The primary outcome was 30-day readmissions. 1.36, p=0.002).

Myocardial Infarction 40

Myocardial Infarction Hospital Hypertension Pulmonary 40

Journal of the American Heart Association

MARCH 26, 2025

Multivariable logistic regression models were used to estimate BMIstratified associations between SMuRFless status and outcomes.ResultsThe study included 44 538 patients with firstpresentation acute myocardial infarction, of whom 4454 were SMuRFless. Journal of the American Heart Association, Ahead of Print.

Myocardial Infarction 40

Myocardial Infarction Risk Factors BMI Obesity 40

Frontiers in Cardiovascular Medicine

JANUARY 3, 2024

Background Microcirculatory dysfunction is an independent risk factor for a poor prognosis after percutaneous coronary intervention (PCI) in patients with acute myocardial infarction (AMI). Cardiac function was measured by echocardiography during hospitalization and follow-up.

Myocardial Infarction 59

Myocardial Infarction Outcomes Cardiac Function Thrombolysis 59

Journal of the American Heart Association

FEBRUARY 19, 2025

BackgroundThere may be variability in willingness to perform percutaneous coronary intervention (PCI) in higherrisk patients who present with STsegmentelevation myocardial infarction (STEMI). We compared patientlevel characteristics of patients who did and did not undergo PCI at each hospital. versus 7.4%,P<0.001),

Myocardial Infarction 40

Myocardial Infarction Hospital STEMI Cardiac Arrest 40

Frontiers in Cardiovascular Medicine

NOVEMBER 19, 2024

This meta-analysis aimed to assess its impact on outcomes.MethodsA search of Medline and Cochrane up to February 2023 was conducted to identify randomized controlled trials and observational studies comparing patients undergoing early CAG vs. delayed/no CAG after experiencing out-of-hospital cardiac arrest.

Cardiac Arrest 59

Cardiac Arrest Myocardial Infarction Hospital Diabetes 59

Medical Xpress - Cardiology

JUNE 10, 2024

A new study by investigators at Massachusetts General Hospital (MGH) reveals an important step to help the human heart regenerate after myocardial infarction (MI).

Heart Attack 75

Heart Attack Heart attacks Myocardial Infarction Hospital 75

Frontiers in Cardiovascular Medicine

JANUARY 13, 2025

BackgroundThe pharmacoinvasive (PhI) strategy is the standard-of-care for ST-elevation myocardial infarction (STEMI) patients when primary percutaneous coronary intervention (pPCI) is unfeasible. Optimal timing for post-fibrinolytic PCI (lysis-PCI) remains elusive.

Myocardial Infarction 52

Myocardial Infarction Outcomes STEMI Hospital 52

Frontiers in Cardiovascular Medicine

OCTOBER 7, 2024

BackgroundIn Thailand, access to specific pharmaceuticals and medical devices for ST-elevation myocardial infarction (STEMI) patients is restricted within certain healthcare systems, leading to inequalities in the quality of medical care among different healthcare systems.

Public Health 52

Public Health Myocardial Infarction STEMI Coronary Artery Disease 52

American College of Cardiology

AUGUST 12, 2024

What are the trends in follow-up after acute myocardial infarction (AMI) and heart failure (HF) hospitalization?

Hospital 45

Hospital Myocardial Infarction Heart Failure Article 45

Dr. Smith's ECG Blog

MARCH 19, 2024

This case was sent by Amandeep (Deep) Singh at Highland Hospital, part of Alameda Health System. The patient presented to an outside hospital An 80yo female per triage “patient presents with chest pain, also hurts to breathe” PMH: CAD, s/p stent placement, CHF, atrial fibrillation, pacemaker (placed 1 month earlier), LBBB. 2023;131569.

Chest Pain 111

Chest Pain Myocardial Infarction Stent Stents 111

Heart BMJ

MARCH 22, 2024

Objective To investigate the incidence and mortality risk associated with postdischarge major bleeding after coronary artery bypass grafting (CABG), and relate this to the incidence of, and mortality risk from, postdischarge myocardial infarction. Myocardial infarction was associated with higher mortality risk <30 days (aHR=20.0 (95%

Coronary Artery Bypass Graft 40

Coronary Artery Bypass Graft Myocardial Infarction Hospital 40